Dihexa

What is Dihexa?

Dihexa is a synthetic hexapeptide that grew out of angiotensin IV research at Washington State University. It drew attention because in laboratory studies it forms new synapses at very low concentrations, which is why you see it described as one of the most potent synaptogenic compounds studied. Read the next section carefully, though: nearly all of that reputation rests on animal and cell work. Dihexa is not approved anywhere and is sold only as a research compound.

How Dihexa works

The proposed mechanism sets Dihexa apart from most nootropic peptides. Rather than hitting a neurotransmitter receptor, it is thought to bind hepatocyte growth factor (HGF) and boost its ability to activate the c-Met receptor. It does not bind c-Met directly. In animal studies that HGF/c-Met signaling drives the growth of dendritic spines and the formation of new synaptic connections, which is the basis for its cognitive claims.

What the research shows

This is where honesty matters most. Dihexa has never been tested in a controlled human trial. The evidence is preclinical: rodent models of learning and memory and cell studies of synapse formation, much of it originating from one research group, with some later independent replication in Alzheimer's-model mice. That is genuinely interesting early science, but it is a long way from proof in people. Treat any claim of a proven human benefit as unsupported.

Dosage and how it is used

There is no established human dose. Every dosing figure in circulation is extrapolated from rodent studies or anecdote, not from human research. Because the effect is described as extremely potent, guessing a dose is not a low-stakes exercise.

→ How to reconstitute Dihexa: calculator, units to draw & storage

Side effects and safety

There is no meaningful human safety data for Dihexa. The theoretical concern worth naming is that HGF/c-Met is a growth-factor pathway involved in cell proliferation, so strongly and chronically activating it raises questions that simply have not been studied in humans. This is a proceed-with-caution compound: potent on paper, essentially unmapped in people.

• No human trials and no human safety record. All effect data is animal or cell-based.
• Acts on a growth-factor pathway tied to cell proliferation, an unstudied long-term concern.
• Not FDA-approved and not approved anywhere. Verify current legal status independently.

Frequently asked questions

References

• Benoist CC et al. The procognitive and synaptogenic effects of angiotensin IV-derived peptides depend on activation of the HGF/c-Met system. J Pharmacol Exp Ther, 2014.
• Dihexa. Cognitive Vitality, Alzheimer's Drug Discovery Foundation.